Richard Bernstein Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,181	Closed	-$912K	–	250
2025 Q4	$912K	Sell	1,181 -140	-11%	-$95.1K	0.03%	139
2025 Q3	$743K	Sell	1,321 -2,449	-65%	-$1.38M	0.02%	182
2025 Q2	$1.98M	Hold	3,770	–	–	0.05%	179
2025 Q1	$2.39M	Sell	3,770 -131	-3%	-$90.1K	0.06%	182
2024 Q4	$2.78M	Hold	3,901	–	–	0.06%	176
2024 Q3	$4.1M	Hold	3,901	–	–	0.09%	108
2024 Q2	$4.1M	Hold	3,901	–	–	0.09%	89
2024 Q1	$3.75M	Hold	3,901	–	–	0.08%	104
2023 Q4	$3.43M	Buy	3,901 +421	+12%	+$347K	0.08%	100
2023 Q3	$2.86M	Hold	3,480	–	–	0.06%	109
2023 Q2	$2.5M	Hold	3,480	–	–	0.05%	132
2023 Q1	$2.86M	Hold	3,480	–	–	0.06%	128
2022 Q4	$2.51M	Buy	+3,480	New	+$2.57M	0.06%	137